116 related articles for article (PubMed ID: 25420279)
1. Flicking the switch: adult hemoglobin expression in erythroid cells derived from cord blood and human induced pluripotent stem cells.
Cantú I; Philipsen S
Haematologica; 2014 Nov; 99(11):1647-9. PubMed ID: 25420279
[No Abstract] [Full Text] [Related]
2. Induction of adult levels of β-globin in human erythroid cells that intrinsically express embryonic or fetal globin by transduction with KLF1 and BCL11A-XL.
Trakarnsanga K; Wilson MC; Lau W; Singleton BK; Parsons SF; Sakuntanaga P; Kurita R; Nakamura Y; Anstee DJ; Frayne J
Haematologica; 2014 Nov; 99(11):1677-85. PubMed ID: 25107887
[TBL] [Abstract][Full Text] [Related]
3. Developmental biology. From genetic association to genetic switch.
Michelson AM
Science; 2008 Dec; 322(5909):1803-4. PubMed ID: 19095932
[No Abstract] [Full Text] [Related]
4. Reversing the hemoglobin switch.
Sankaran VG; Nathan DG
N Engl J Med; 2010 Dec; 363(23):2258-60. PubMed ID: 21121839
[No Abstract] [Full Text] [Related]
5. [BCL11A controls the expression of the human fetal hemoglobin].
Labie D
Med Sci (Paris); 2012 Nov; 28(11):923-5. PubMed ID: 23171892
[No Abstract] [Full Text] [Related]
6. Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A.
Sankaran VG; Menne TF; Xu J; Akie TE; Lettre G; Van Handel B; Mikkola HK; Hirschhorn JN; Cantor AB; Orkin SH
Science; 2008 Dec; 322(5909):1839-42. PubMed ID: 19056937
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin and t-butylhydroquinone suppress KLF1 and BCL11A gene expression and additively increase fetal hemoglobin in primary human erythroid cells.
Macari ER; Schaeffer EK; West RJ; Lowrey CH
Blood; 2013 Jan; 121(5):830-9. PubMed ID: 23223429
[TBL] [Abstract][Full Text] [Related]
8. let-7 miRNAs repress HIC2 to regulate BCL11A transcription and hemoglobin switching.
Huang P; Peslak SA; Shehu V; Keller CA; Giardine B; Shi J; Hardison RC; Blobel GA; Khandros E
Blood; 2024 May; 143(19):1980-1991. PubMed ID: 38364109
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional mechanisms underlying hemoglobin synthesis.
Katsumura KR; DeVilbiss AW; Pope NJ; Johnson KD; Bresnick EH
Cold Spring Harb Perspect Med; 2013 Sep; 3(9):a015412. PubMed ID: 23838521
[TBL] [Abstract][Full Text] [Related]
10. Featured Article: Modulation of fetal hemoglobin in hereditary persistence of fetal hemoglobin deletion type-2, compared to Sicilian δβ-thalassemia, by BCL11A and SOX6-targeting microRNAs.
Fornari TA; Lanaro C; Albuquerque DM; Ferreira R; Costa FF
Exp Biol Med (Maywood); 2017 Feb; 242(3):267-274. PubMed ID: 27591578
[TBL] [Abstract][Full Text] [Related]
11. Dual function NFI factors control fetal hemoglobin silencing in adult erythroid cells.
Qin K; Huang P; Feng R; Keller CA; Peslak SA; Khandros E; Saari MS; Lan X; Mayuranathan T; Doerfler PA; Abdulmalik O; Giardine B; Chou ST; Shi J; Hardison RC; Weiss MJ; Blobel GA
Nat Genet; 2022 Jun; 54(6):874-884. PubMed ID: 35618846
[TBL] [Abstract][Full Text] [Related]
12. Hemoglobin switching's surprise: the versatile transcription factor BCL11A is a master repressor of fetal hemoglobin.
Bauer DE; Orkin SH
Curr Opin Genet Dev; 2015 Aug; 33():62-70. PubMed ID: 26375765
[TBL] [Abstract][Full Text] [Related]
13. Putting a finger on the switch.
Bieker JJ
Nat Genet; 2010 Sep; 42(9):733-4. PubMed ID: 20802474
[TBL] [Abstract][Full Text] [Related]
14. Update on fetal hemoglobin gene regulation in hemoglobinopathies.
Bauer DE; Orkin SH
Curr Opin Pediatr; 2011 Feb; 23(1):1-8. PubMed ID: 21157349
[TBL] [Abstract][Full Text] [Related]
15. Medicine. Sickle cell disease at 100 years.
Orkin SH; Higgs DR
Science; 2010 Jul; 329(5989):291-2. PubMed ID: 20647458
[No Abstract] [Full Text] [Related]
16. HIC2 controls developmental hemoglobin switching by repressing BCL11A transcription.
Huang P; Peslak SA; Ren R; Khandros E; Qin K; Keller CA; Giardine B; Bell HW; Lan X; Sharma M; Horton JR; Abdulmalik O; Chou ST; Shi J; Crossley M; Hardison RC; Cheng X; Blobel GA
Nat Genet; 2022 Sep; 54(9):1417-1426. PubMed ID: 35941187
[TBL] [Abstract][Full Text] [Related]
17. Genetics. GWAS to therapy by genome edits?
Hardison RC; Blobel GA
Science; 2013 Oct; 342(6155):206-7. PubMed ID: 24115432
[No Abstract] [Full Text] [Related]
18. Identification of novel candidate genes for globin regulation in erythroid cells containing large deletions of the human beta-globin gene cluster.
de Andrade TG; Peterson KR; Cunha AF; Moreira LS; Fattori A; Saad ST; Costa FF
Blood Cells Mol Dis; 2006; 37(2):82-90. PubMed ID: 16952470
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulators Myb and BCL11A interplay with DNA methyltransferase 1 in developmental silencing of embryonic and fetal β-like globin genes.
Roosjen M; McColl B; Kao B; Gearing LJ; Blewitt ME; Vadolas J
FASEB J; 2014 Apr; 28(4):1610-20. PubMed ID: 24371119
[TBL] [Abstract][Full Text] [Related]
20. Erythroid activator NF-E2, TAL1 and KLF1 play roles in forming the LCR HSs in the human adult β-globin locus.
Kim YW; Yun WJ; Kim A
Int J Biochem Cell Biol; 2016 Jun; 75():45-52. PubMed ID: 27026582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
